|
|
Volumn 55, Issue 1, 2002, Pages 1-2
|
|
Antiarrhythmic drug development - Illusion and disillusion?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE;
ANTIARRHYTHMIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
ION CHANNEL;
MATRIX METALLOPROTEINASE;
NORADRENALIN;
QUINIDINE;
SODIUM PROTON EXCHANGE PROTEIN;
ATRIOVENTRICULAR CONDUCTION;
DEFIBRILLATION;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SELECTIVITY;
EDITORIAL;
HEART ARRHYTHMIA;
HEART ELECTROPHYSIOLOGY;
HEART MUSCLE REFRACTORY PERIOD;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
MORBIDITY;
MORTALITY;
PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA;
POTASSIUM CURRENT;
|
|
EID: 0036221289
PISSN: 02724391
EISSN: None
Source Type: Journal
DOI: 10.1002/ddr.10035 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
